PO-0778: Delineation of the regional nodal areas in breast radiotherapy: What are the most problematic regions?  by Verhoeven, K. et al.
S388                                                                                                                                         3rd ESTRO Forum 2015 
 
volume delineation. Reasons for non-compliance are mostly 
problems with target coverage. Thirty-eight percent of the 
centers reported issues with target coverage; in 1 center 
they interpret the Dose Volume Histogram differently and are 
now looking at the 85% coverage of the planning target 
volume instead of the 95%. 
Conclusions: The introduction of new delineation guidelines 
for the RNA in breast radiotherapy has a major impact on the 
treatment planning and dosimetry with especially introducing 
newer treatment techniques to achieve better target 
coverage. Surprisingly, not all centers use the centrally 
reviewed and corrected target delineation to guide their 
radiotherapy to the RNA.  
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Purpose/Objective: In the era of fast technological evolution 
in breast radiotherapy (RT), a correct delineation of the 
target volumes becomes more and more important. The 
objective in this study is to investigate the performance of 
the accuracy of the delineation of the regional nodal areas 
(RNA) by different radiation-oncologists and to determine the 
most difficult regions to contour. 
Materials and Methods: Before the start of the national 
central review study for the delineation of the RNA in breast 
RT, all participating centers were asked to delineate all the 
different RNA on a CT-scan with intravenous contrast of one 
specific patient. The delineation guidelines as well as the 
delineation atlases, covering both target volumes and normal 
anatomy, were provided. The obtained contours were 
compared with the reference contour to evaluate the 
conformity using the overlapping volume (OV). The OV is 
defined by the intersection of the obtained contour with the 
reference contour divided by the union of those contours.  
Results: Twenty-two radiation-oncologists of 15 different 
radiotherapy departments performed the delineation of the 
RNA of that one specific case. In general, the mean OV of all 
lymph node regions together was 0.52 (± std 0.12). The most 
problematic areas were the rotter space and the internal 
mammary lymph node region (figure), with a mean OV of 
respectively 0.42 (± std 0.09) and 0.48 (± std 0.09). Level IV 
(= supraclavicular) and level I of the axilla were contoured 
the best with a mean OV of 0.6 (± std 0.13) and 0.56 (± std 
0.08), followed by level III and level II of the axilla with a 
mean OV of respectively 0.53 (± std 0.11) and 0.51 (± std 
0.11). 
Conclusions: Delineation of the regional nodal areas in breast 
radiotherapy is not easy with a large intercenter and 
interobserver variation, even in the presence of extensively 
written guidelines and clear atlases. The most difficult areas 
to contour in this pilot study were the rotter space and the 
internal mammary node region. The national central review 
study will tell us if practicing and central review lead to 
better contouring. 
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Purpose/Objective: Upper abdominal SBRT is significantly 
compromised by late toxicity to bowel structures, mostly 
stomach, duodenum and small bowel and to a lesser degree 
also colon. Often ablative doses cannot be prescribed without 
infringement of dose constraints to bowel organs at risk 
(OAR), limiting SBRT to selected places had distant from 
bowel structures. 
Materials and Methods: We developed a method of SBRT 
where all doses were prescribed according to ICRU 
guidelines. After generation of the main planning target 
volume (PTV) by isotropic expansion of 4 mm from internal 
target volume (ITV) as determined by 4D-imaging. We then 
defined a high dose SIB-PTV by a negative margin of 10 mm of 
the ITV. Dose prescribed to the SIB-PTV was 122-125% of the 
dose prescribed to the main PTV. Additionally, we defined a 
SIP-PTV by subtracting the planning risk volume (PRV) of a 
bowel OAR created by a 4 mm margin expansion of the OAR 
structure. Dose prescribed to the SIP-PTV was chosen to meet 
the defined dose constraints to OARs as described by 
Timmerman in 2008. Two fractionation regimes were used, 5 
or 12 fractions, given every other day. Five fraction regimens 
